Role of plasminogen activator in pemphigus vulgaris.

The role of plasminogen activator (PA) in the pathogenesis of acantholysis in canine pemphigus vulgaris (PV) was evaluated using differentiated cultures of canine oral keratinocytes. Both the secreted and cell-associated PA activity in cultured canine keratinocytes were completely inhibited by specific anti-urokinase antibodies. Anti-tissue type PA antibodies did not inhibit either secreted or cell-associated PA activity. Immunoblots and fibrin zymography revealed a single 57,000 molecular weight urokinase-type PA in the conditioned media of the canine oral keratinocytes. Incubation of the differentiated cultures with PV Ig resulted in a significant increased in the levels of PA activity and both canine and human PV Ig were effective at inducing acantholysis typical of that seen in the clinical disease. The addition of urokinase inhibitor to the cultures treated with PV Ig prevented the development of acantholysis. These data strongly support the conclusion that PA is involved in acantholysis which is the cardinal feature of PV.

[1]  P. Jensen,et al.  Epidermal plasminogen activator is abnormal in cutaneous lesions. , 1988, The Journal of investigative dermatology.

[2]  V Ottevanger,et al.  Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. , 1988, The Journal of investigative dermatology.

[3]  S. Thorsen,et al.  Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental‐type PAI‐2 , 1988, FEBS letters.

[4]  J. Stanley,et al.  Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. , 1988, The Journal of clinical investigation.

[5]  L. Greenberger,et al.  Monoclonal antibodies: cell surface markers for canine keratinocytes. , 1987, American journal of veterinary research.

[6]  L. Gold,et al.  Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Jensen,et al.  Migrating keratinocytes express urokinase-type plasminogen activator. , 1987, The Journal of investigative dermatology.

[8]  J. Wilkinson,et al.  Long-term cultivation of canine keratinocytes. , 1987, The Journal of investigative dermatology.

[9]  J. Plescia,et al.  The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type , 1986, The Journal of cell biology.

[10]  K. Hashimoto,et al.  Secretion of plasminogen activator inhibitor by cultured human epidermal cells , 1986, The British journal of dermatology.

[11]  J. Schweizer,et al.  Expression of high molecular weight (67K) keratin in human keratinocytes cultured on dead de-epidermized dermis. , 1986, Experimental cell research.

[12]  B. Bernard,et al.  Human epidermis reconstructed by culture: is it "normal"? , 1986, The Journal of investigative dermatology.

[13]  D. Proud,et al.  Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. , 1986, Journal of Immunology.

[14]  P. Jensen,et al.  Human epidermal plasminogen activator. Characterization, localization, and modulation. , 1985, Experimental cell research.

[15]  O. Saksela,et al.  Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.

[16]  K. Hashimoto,et al.  Tissue plasminogen activator inhibitor in the epidermis , 1985, The British journal of dermatology.

[17]  P. Andreasen,et al.  Plasminogen activator in psoriatic scales is of the tissue‐type PA as identified by monoclonal antibodies , 1985, The British journal of dermatology.

[18]  M. Darmon,et al.  Epidermal morphogenesis and induction of the 67 kD keratin polypeptide by culture of human keratinocytes at the liquid-air interface. , 1985, Experimental cell research.

[19]  A. Corti,et al.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Hashimoto,et al.  The effect of corticosteroids, dapsone and gold upon plasminogen activator synthesis and secretion by human epidermal cells cultured with pemphigus antibody , 1984, The British journal of dermatology.

[21]  F. Watt.  Selective migration of terminally differentiating cells from the basal layer of cultured human epidermis , 1984, The Journal of cell biology.

[22]  K. Hashimoto,et al.  Plasminogen activator in cultured human epidermal cells. , 1983, The Journal of investigative dermatology.

[23]  L. Diaz,et al.  Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid. , 1983, Archives of dermatology.

[24]  K. Holbrook,et al.  Phenotypic expression of epidermal cells in vitro: a review. , 1983, The Journal of investigative dermatology.

[25]  J. Voorhees,et al.  Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. , 1983, The Journal of investigative dermatology.

[26]  D. Lawrence,et al.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Birkedal‐Hansen,et al.  Production of three plasminogen activators and an inhibitor in keratinocyte cultures. , 1983, Biochimica et biophysica acta.

[28]  R. Isseroff,et al.  Plasminogen activator in differentiating mouse keratinocytes. , 1983, Journal of Investigative Dermatology.

[29]  B. Katzenellenbogen,et al.  Plasminogen activators in tissues of the immature and estrogen-stimulated rat uterus and in uterine luminal fluid: characterization and properties. , 1983, Endocrinology.

[30]  K. Hashimoto,et al.  Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation , 1983, The Journal of experimental medicine.

[31]  D. Loskutoff,et al.  Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators , 1982, The Journal of cell biology.

[32]  M. Yaar,et al.  Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. , 1982, The Journal of clinical investigation.

[33]  J. Voorhees,et al.  Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.

[34]  R. Lewis,et al.  Pemphigus and pemphigoid in dog and man: comparative aspects. , 1981, Journal of the American Academy of Dermatology.

[35]  D. C. Livingston,et al.  A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinase. , 1981, Biochemistry.

[36]  H. Ogawa,et al.  The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. , 1981, The Journal of investigative dermatology.

[37]  J. Schiltz.  Pemphigus acantholysis: a unique immunological injury. , 1980, The Journal of investigative dermatology.

[38]  M. Wolfe,et al.  The Comparative Pathology of Non-Viral Bullous Skin Diseases in Domestic Animals , 1980, Veterinary pathology.

[39]  A. Ahmed,et al.  Pemphigus: Current Concepts , 1980 .

[40]  Hurvitz Ai.  Animal model of human disease: pemphigus vulgaris. , 1980, The American journal of pathology.

[41]  J. Schiltz,et al.  Corticosteroids, aurothioglucose and soybean trypsin inhibitor do not prevent pemphigus antibody‐induced acantholysis in vitro , 1979, The British journal of dermatology.

[42]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Jenkin,et al.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.

[44]  J. Bystryn,et al.  Absence of intercellular antigens in the deep layers of the epidermis in pemphigus foliaceus. , 1978, The Journal of clinical investigation.

[45]  T. Astrup,et al.  Inhibition by hydrocortison of plasminogen activator production in rat tongue organ cultures. , 1974, Laboratory investigation; a journal of technical methods and pathology.

[46]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[47]  R. Eady,et al.  Blistering in keratinocyte cultures: a regular phenomenon associated with differentiation. , 1986, European journal of cell biology.

[48]  D. Maccallum,et al.  Fine structure of subcultivated stratified squamous epithelium grown on collagen rafts. , 1980, Experimental cell research.

[49]  G. Lazarus,et al.  Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. , 1978, Proceedings of the National Academy of Sciences of the United States of America.